Clinical efficacy of mild therapeutic hypothermia with different rewarming time on neonatal hypoxic-ischemic encephalopathy: a prospective randomized controlled study
LIN Yu-Xin, FENG Xiao, ZHANG Yi-Dan, HONG Wan-Rong, ZHAO Hong-Ying
Department of Pediatrics, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China (Feng X, Email: 1152805588@qq.com)
Abstract：Objective To investigate the clinical efficacy of mild therapeutic hypothermia (MTH) with different rewarming time on neonatal hypoxic-ischemic encephalopathy (HIE). Methods A prospective study was performed on 101 neonates with HIE who were born and received MTH in Zhongshan Hospital, Xiamen University, from January 2018 to January 2022. These neonates were randomly divided into two groups: MTH1 group (n=50; rewarming for 10 hours at a rate of 0.25°C/h) and MTH2 group (n=51; rewarming for 25 hours at a rate of 0.10°C/h). The clinical features and the clinical efficacy were compared between the two groups. A binary logistic regression analysis was used to identify the factors influencing the occurrence of normal sleep-wake cycle (SWC) on amplitude-integrated electroencephalogram (aEEG) at 25 hours of rewarming. Results There were no significant differences between the MTH1 and MTH2 groups in gestational age, 5-minute Apgar score, and proportion of neonates with moderate/severe HIE (P>0.05). Compared with the MTH2 group, the MTH1 group tended to have a normal arterial blood pH value at the end of rewarming, a significantly shorter duration of oxygen dependence, a significantly higher proportion of neonates with normal SWC on aEEG at 10 and 25 hours of rewarming, and a significantly higher Neonatal Behavioral Neurological Assessment score on days 5, 12, and 28 after birth (P<0.05), while there was no significant difference in the incidence rate of rewarming-related seizures between the two groups (P>0.05). There were no significant differences between the two groups in the incidence rate of neurological disability at 6 months of age and the score of Bayley Scale of Infant Development at 3 and 6 months of age (P>0.05). The binary logistic regression analysis showed that prolonged rewarming time (25 hours) was not conducive to the occurrence of normal SWC (OR=3.423, 95%CI: 1.237-9.469, P=0.018). Conclusions Rewarming for 10 hours has a better short-term clinical efficacy than rewarming for 25 hours. Prolonging rewarming time has limited clinical benefits on neonates with moderate/severe HIE and is not conducive to the occurrence of normal SWC, and therefore, it is not recommended as a routine treatment method.
LIN Yu-Xin,FENG Xiao,ZHANG Yi-Dan et al. Clinical efficacy of mild therapeutic hypothermia with different rewarming time on neonatal hypoxic-ischemic encephalopathy: a prospective randomized controlled study[J]. CJCP, 2023, 25(4): 350-356.
Birca A, Lortie A, Birca V, et al. Rewarming affects EEG background in term newborns with hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia[J]. Clin Neurophysiol, 2016, 127(4): 2087-2094. PMID: 26749567. DOI: 10.1016/j.clinph.2015.12.013.
Benedetti GM, Vartanian RJ, McCaffery H, et al. Early electroencephalogram background could guide tailored duration of monitoring for neonatal encephalopathy treated with therapeutic hypothermia[J]. J Pediatr, 2020, 221: 81-87.e1. PMID: 32222256. DOI: 10.1016/j.jpeds.2020.01.066.
Meder U, Cseko AJ, Szakacs L, et al. Longitudinal analysis of amplitude-integrated electroencephalography for outcome prediction in hypoxic-ischemic encephalopathy[J]. J Pediatr, 2022, 246: 19-25.e5. PMID: 35430248. DOI: 10.1016/j.jpeds.2022.04.013.
Thayyil S, Pant S, Montaldo P, et al. Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri Lanka, and Bangladesh[J]. Lancet Glob Health, 2021, 9(9): e1273-e1285. PMID: 34358491. PMCID: PMC8371331. DOI: 10.1016/S2214-109X(21)00264-3.
Kinoshita AN, Magalh?es M, Rodrigues DP, et al. Effectiveness of reaching and maintaining therapeutic hypothermia target temperature using low-cost devices in newborns with hypoxic-ischemic encephalopathy[J]. Anat Rec (Hoboken), 2021, 304(6): 1217-1223. PMID: 33729705. DOI: 10.1002/ar.24615.
Davidson JO, Wassink G, Draghi V, et al. Limited benefit of slow rewarming after cerebral hypothermia for global cerebral ischemia in near-term fetal sheep[J]. J Cereb Blood Flow Metab, 2019, 39(11): 2246-2257. PMID: 30092709. PMCID: PMC6827112. DOI: 10.1177/0271678X18791631.
Mitra S, Bale G, de Roever I, et al. Changes in brain tissue oxygenation and metabolism during rewarming after neonatal encephalopathy are related to electrical abnormality[J]. Adv Exp Med Biol, 2020, 1232: 25-31. PMID: 31893390. DOI: 10.1007/978-3-030-34461-0_4.
Jain P, Dalal JS, Gathwala G. Rapid vs. slow rewarming for management of moderate to severe hypothermia in low-birth-weight pre-term neonates—an open label randomized controlled trial[J]. J Trop Pediatr, 2021, 67(1): fmaa098. PMID: 33381805. DOI: 10.1093/tropej/fmaa098.
Delval A, Girard B, Lacan L, et al. Neurophysiological recordings improve the accuracy of the evaluation of the outcome in perinatal hypoxic ischemic encephalopathy[J]. Eur J Paediatr Neurol, 2022, 36: 51-56. PMID: 34890946. DOI: 10.1016/j.ejpn.2021.11.010.
